FDA Issues Warning On Voltaren Gel Liver Risks
The U.S. Food and Drug Administration has issued a warning to health care professionals that Novartis AG and Endo Pharmaceuticals Inc.'s topical pain reliever Voltaren Gel carries a risk of potentially...To view the full article, register now.
Already a subscriber? Click here to view full article